Hypertension in People with Multiple Sclerosis
A narrative review examined existing research on hypertension prevalence among people with multiple sclerosis (PwMS) and potential mechanisms linking the two, such as immunological and vascular pathways. However, the review did not establish conclusive evidence regarding the prevalence or implications of hypertension in PwMS.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Other
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
Understanding the relationship between hypertension and MS is crucial, as it may impact treatment approaches and patient outcomes, yet the underlying mechanisms remain unclear.
What this does not prove
The review does not provide definitive conclusions about hypertension's prevalence or its impact on MS-related outcomes.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-13
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceHypertension in People with Multiple Sclerosis: Epidemiology, Mechanisms, Hypertensive Disorders of Pregnancy, and Clinical Implications. ↗DOI: 10.3390/diseases14100376
Supporting passages (6)
publication datePublication date: 2026-10-13
findingsThis narrative review summarizes current evidence on the prevalence of hypertension in PwMS, examines potential immunological, autonomic, vascular, behavioral, and treatment-related pathways that may link MS and hypertension, and explores how MS disease-modifying therapies may influence blood pressure regulation.
mechanismsexplores how MS disease-modifying therapies may influence blood pressure regulation.
limitationsTitle: Hypertension in People with Multiple Sclerosis: Epidemiology, Mechanisms, Hypertensive Disorders of Pregnancy, and Clinical Implications.
peer reviewedPublication types: Journal Article; Review
subjectsTitle: Hypertension in People with Multiple Sclerosis: Epidemiology, Mechanisms, Hypertensive Disorders of Pregnancy, and Clinical Implications.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.